HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 90/3/1936    most recent 01150.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by McQuiston, A. R. Articles by Saggau, P. Search for Related Content PubMed PubMed Citation Articles by McQuiston, A. R. Articles by Saggau, P.

Mu-opioid Receptors Facilitate the Propagation of Excitatory Activity in Rat Hippocampal Area CA1 by Disinhibition of all Anatomical Layers

Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030

Submitted 20 December 2002; accepted in final form 7 May 2003

Hippocampal µ-opioid receptors (MORs) have been implicated in memory formation associated with opiate drug abuse. MORs modulate hippocampal synaptic plasticity acutely, when chronically activated, and during drug withdrawal. At the network level, MORs increase excitability in area CA1 by disinhibiting pyramidal cells. The precise inhibitory interneuron subtypes affected by MOR activation are unknown; however, not all subtypes are inhibited, and specific interneuron subtypes have been shown to preferentially express MORs. Here we investigate, using voltage-sensitive dye imaging in brain slices, the effect of MOR activation on the patterns of inhibition and on the propagation of excitatory activity in rat hippocampal CA1. MOR activation augments excitatory activity evoked by stimulating inputs in stratum oriens [i.e., Schaffer collateral and commissural pathway (SCC) and antidromic], stratum radiatum (i.e., SCC), and stratum lacunosum-moleculare (SLM; i.e., perforant path and thalamus). The augmented excitatory activity is further facilitated as it propagates through the CA1 network. This was observed as a proportionately larger increase in amplitudes of excitatory activity at sites distal from where the activity was evoked. This facilitation was observed for excitatory activity propagating from all three stimulation sites. The augmentation and facilitation were prevented by GABA_A receptor antagonists (bicuculline, 30 µM), but not by GABA_B receptor antagonists (CGP 55845, 10 µM). Furthermore, MOR activation inhibited IPSPs in all layers of area CA1. These findings suggest that MOR-induced suppression of GABA release onto GABA_A receptors augments all inputs to CA1 pyramidal cells and facilitates the propagation of excitatory activity through the network of area CA1.

This article has been cited by other articles:

				S. Loacker, M. Sayyah, W. Wittmann, H. Herzog, and C. Schwarzer Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors Brain, April 1, 2007; 130(4): 1017 - 1028. [Abstract] [Full Text] [PDF]

				L. Formisano, K.-M. Noh, T. Miyawaki, T. Mashiko, M. V. L. Bennett, and R. S. Zukin Ischemic insults promote epigenetic reprogramming of {micro} opioid receptor expression in hippocampal neurons PNAS, March 6, 2007; 104(10): 4170 - 4175. [Abstract] [Full Text] [PDF]

				A. R. McQuiston Effects of {micro}-Opioid Receptor Modulation on GABAB Receptor Synaptic Function in Hippocampal CA1 J Neurophysiol, March 1, 2007; 97(3): 2301 - 2311. [Abstract] [Full Text] [PDF]

				J.-W. Yang, H.-C. Shih, and B.-C. Shyu Intracortical Circuits in Rat Anterior Cingulate Cortex Are Activated by Nociceptive Inputs Mediated by Medial Thalamus J Neurophysiol, December 1, 2006; 96(6): 3409 - 3422. [Abstract] [Full Text] [PDF]

				V. Szegedi, G. Juhasz, E. Rozsa, G. Juhasz-Vedres, Z. Datki, L. Fulop, Z. Bozso, A. Lakatos, I. Laczko, T. Farkas, et al. Endomorphin-2, an endogenous tetrapeptide, protects against A{beta}1-42 in vitro and in vivo FASEB J, June 1, 2006; 20(8): 1191 - 1193. [Abstract] [Full Text] [PDF]